Sirolimus-induced secondary pulmonary alveolar proteinosis

por Wang, Stephanie, Lee, Elinor, Lau, Ryan, Wang, Tisha
Publicado 2021

Opportunistic Infection Associated With Elevated GM-CSF Autoantibodies: A Case Series and Review of the Literature

por Lee, Elinor, Miller, Christopher, Ataya, Ali, Wang, Tisha
Publicado 2022

The Role of GM-CSF Autoantibodies in Infection and Autoimmune Pulmonary Alveolar Proteinosis: A Concise Review

por Ataya, Ali, Knight, Vijaya, Carey, Brenna C., Lee, Elinor, Tarling, Elizabeth J., Wang, Tisha
Publicado 2021

Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies

por Bonaventura, Aldo, Vecchié, Alessandra, Wang, Tisha S., Lee, Elinor, Cremer, Paul C., Carey, Brenna, Rajendram, Prabalini, Hudock, Kristin M., Korbee, Leslie, Van Tassell, Benjamin W., Dagna, Lorenzo, Abbate, Antonio
Publicado 2020

Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders

por Lazarus, Hillard M., Pitts, Katherine, Wang, Tisha, Lee, Elinor, Buchbinder, Elizabeth, Dougan, Michael, Armstrong, David G., Paine, Robert, Ragsdale, Carolyn E., Boyd, Timothy, Rock, Edwin P., Gale, Robert Peter
Publicado 2023

Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis

por McCarthy, Cormac, Lee, Elinor, Bridges, James P., Sallese, Anthony, Suzuki, Takuji, Woods, Jason C., Bartholmai, Brian J., Wang, Tisha, Chalk, Claudia, Carey, Brenna C., Arumugam, Paritha, Shima, Kenjiro, Tarling, Elizabeth J., Trapnell, Bruce C.
Publicado 2018